Early clinical experience of bacteriophage therapy in 3 lung transplant recipients

Author:

Aslam Saima1ORCID,Courtwright Andrew M.2,Koval Christine3,Lehman Susan M.4,Morales Sandra4,Furr Carrie‐Lynn Langlais4,Rosas Francisco4,Brownstein Michael J.5,Fackler Joseph R.5,Sisson Brittany M.5,Biswas Biswajit6,Henry Matthew6,Luu Truong6,Bivens Brittany N.6,Hamilton Theron6,Duplessis Christopher6,Logan Cathy1,Law Nancy1,Yung Gordon7,Turowski Jason8,Anesi Judith9ORCID,Strathdee Steffanie A.1,Schooley Robert T.1

Affiliation:

1. Division of Infectious Diseases and Global Public Health University of California San Diego La Jolla California

2. Department of Pulmonary and Critical Care Medicine University of Pennsylvania Philadelphia Pennsylvania

3. Department of Infectious Diseases Cleveland Clinic Foundation Cleveland Ohio

4. AmpliPhi Biosciences San Diego California

5. Adaptive Phage Therapeutics Gaithersburg Maryland

6. Naval Medical Research Center Biological Defense Research Directorate Fort Detrick Maryland

7. Division of Pulmonary Critical Care & Sleep Medicine University of California San Diego La Jolla California

8. Department of Pulmonary Medicine Cleveland Clinic Foundation Cleveland Ohio

9. Division of Infectious Diseases University of Pennsylvania Philadelphia Pennsylvania

Funder

National Institutes of Health

U.S. Navy

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3